Abbott Laboratories (NYSE:ABT) went higher by +1.92% to close at $ 39.31. The company exchanged total volume of 10.42 million shares throughout course of last trade however it holds an average trading capacity of 10.08 million shares. Shares of company began trading at $38.65 climbed to high of $39.31 touched the low of $38.57.
The company is trading above its 50-day moving averages of 38.26 and down from 200-day moving averages of 40.22. The firm has price to book ratio of 2.73 and its price to sale ratio was 2.78.
Abbott Laboratories’s (ABT) has price-to-cash ratio of 14.59 and price to sale ratio of 2.83. The company net profit margin is 12.00% and gross profit margin is 56.90%. A look on the firm performance, its monthly performance is -0.48% and a quarterly performance of -6.26%. The stock price is moving up from its 20 days moving average with 2.68% and isolated positively from 50 days moving average with 0.78%.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) dropped -0.68% and closed the trade at $ 4.39. The company recorded a trading capacity of 1.71 million shares below its three months average daily volume of 3.33 million shares. During the last trade, shares reached to high price of $4.47 and touched the low price of $4.31. The stock’s 50-day moving average is noted at $4.26 and its 200-day moving average is stands at $6.76.
Additionally, the company has EPS of -1.34. The company has market capitalization of $433.37M.
The average true range of Celldex Therapeutics, Inc.’s (CLDX) is recorded at 0.27 and the relative strength index of the stock stands 51.14. The stock price is going above to its 52 week low with 48.31% and lagging behind from its 52 week high with -84.37%. Analyst recommendation for this stock stands at 2.30. A look on the firm performance, its monthly performance is -3.52% and a quarterly performance of 11.14%. The stock price is trading downbeat from its 200 days moving average with -51.64% and up from 50 days moving average with 5.41%.